Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Dawson James Downgrades BioCardia to Neutral

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

Analyst Ratings

Where Amazon.com Stands With Analysts

By Benzinga Insights

Today, 4:56 AM

Amazon.com (NASDAQ:AMZN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

AMZN

Argus Research Maintains Buy on Exxon Mobil, Raises Price Target to $104

By Benzinga Newsdesk

Today, 4:56 AM

Argus Research analyst Bill Selesky maintains Exxon Mobil (NYSE:XOM) with a Buy and raises the price target from $92 to $104.

XOM

AAR Awarded First Captains Of Industry Contract By The U.S. Department Of Defense’s DLA Focused On Distribution Of Sustainment Services; Terms Not Disclosed

By Benzinga Newsdesk

Today, 4:56 AM

AAR CORP. (NYSE:AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has been awarded a Captains of Industry contract with the Defense Logistics Agency (DLA), establishing

AIR

Kimberly-Clark Stock Slides Post Mixed Q4 Results; Boosts Dividend By 1.7%

By Shivani Kumaresan

Today, 4:56 AM

Kimberly-Clark Corp (NYSE:KMB) reported fourth-quarter FY22 sales flat at $4.96 billion, missing the consensus of $4.98 billion. Organic sales increased by…

KMB

Dawson James Downgrades BioCardia to Neutral

Related Posts

Where Amazon.com Stands With Analysts

Argus Research Maintains Buy on Exxon Mobil, Raises Price Target to $104

AAR Awarded First Captains Of Industry Contract By The U.S. Department Of Defense’s DLA Focused On Distribution Of Sustainment Services; Terms Not Disclosed

Kimberly-Clark Stock Slides Post Mixed Q4 Results; Boosts Dividend By 1.7%